 |
| Dr Fabien Vincent |
School of Clinical Sciences’ researcher Dr Fabien Vincent is
the recipient of the Rebecca L.
Cooper Medical Research Foundation Project Grant, enabling vital
research into lupus.
A Research Fellow in the Rheumatology
Research Group, Dr Vincent is the lead investigator on the study
that aims to identify molecular signatures in Indigenous Australians with
systemic lupus erythematosus (lupus).
Lupus is an incurable and severe chronic systemic illness,
and for unknown reasons, is two to four times more frequent and severe in Indigenous
Australians compared with other Australians.
Dr Vincent said the diagnostic label of
lupus comprises different groups of patients, who can potentially be
characterised by the measurement of singular markers in their blood.
“However, the biological profile of
Indigenous Australians with lupus is unknown, limiting their access to emerging
targeted treatments,” Dr Vincent said.
“Identifying blood signatures in Indigenous
Australians with lupus will increase our understanding of the disease at the
molecular level, ultimately affecting the management of the disease.”
“Our ultimate goal is to help developing personalised
and targeted therapies to improve the health status of Indigenous Australians,
to help to close the health gap between Indigenous
and non-Indigenous Australian lupus sufferers, as well as better
understanding of lupus pathogenesis per se,” Dr Vincent said.
The Rheumatology Research Group is led by Professor Eric
Morand, an internationally recognised expert in lupus.
See more
information about Lupus at The
Conversation.
No comments:
Post a Comment